Last reviewed · How we verify
Biodentine
At a glance
| Generic name | Biodentine |
|---|---|
| Also known as | Active biosilicate. Septodont., Septodont Biodentine; Calcium Silicate Cement, Dentine substitute material, 77509635, Biodenine |
| Sponsor | Universidad de los Andes, Chile |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Biodentine Pulpotomy vs Metapex Pulpectomy in Primary Molars: Clinical & Radiographic Comparison of Outcomes in Irreversible Pulpitis Cases (NA)
- Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis (NA)
- Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth (PHASE4)
- Compare Between the Effect of CGF and PRF on Revascularization of Immature Roots of the Mandibular Permanent First Molar (NA)
- Survival and Success of Two Different Filling Techniques (NA)
- Comparative Evaluation of Post Obturation Pain After Root Canal Treatment Using Tricalcium Silicate vs Resin-Based Sealers (NA)
- Vital Pulp Treatment in Primary Teeth (PHASE4)
- A Comparative Clinical Study Assessing Dentin Thickness and Discoloration in Deep Carious Lesions Treated With Biodentine Alone Versus Diode Laser Pre-treatment Followed by Biodentine (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Biodentine CI brief — competitive landscape report
- Biodentine updates RSS · CI watch RSS
- Universidad de los Andes, Chile portfolio CI